This is Mint Hospital, providing true healing.
Mint Hospital · Non-benefit items
Non-covered (Uninsured) Services
Notice
- The procedure fee is the cost of a single individual item and may vary depending on the number of procedures and scope; if medical supplies and medications are required, they will be calculated separately.
- Legal Basis: This is an inquiry screen for notifying non-covered medical expenses pursuant to Article 45, Paragraphs 1 and 2 of the Medical Service Act and Article 42-2, Paragraphs 1, 2, and 3 of the Enforcement Rules of the same Act.
You can move left and right to view the table.
| Main Category | Medium category | Subcategories | item | Category | Price Information (Unit: Won) | Whether medical supplies are included | Whether medication costs are included | significant | Last modified date | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | Item name | cost | Lowest cost | Maximum cost | ||||||||
| drugs | 647205802 | Zinc Power Injection 10mL (Zinc Sulfate Hydrate) | 12,000 | 2026-09-22 | ||||||||
| drugs | 670801521 | Maunzaro Vial Injection 15 mg/0.5 mL (Terzepatide) [4 pens] | 750,000 | 2026-09-21 | ||||||||
| drugs | 670801511 | Maunzaro Vial Injection 12.5 mg/0.5 mL (Terzepatide) [4 pens] | 720,000 | 2026-09-21 | ||||||||
| drugs | 655502201 | Capxive pre-filled syringe 0.5mL | 180000 | 2026-09-15 | ||||||||
| Act | Chapter 2 Examination Fees | C3500A | FSH [Non-covered] | 15,000 | 2026-09-08 | |||||||
| drugs | 3Z5201118 | Skycellflu 3-valent pre-filled syringe | 35,000 | 2026-08-31 | ||||||||
| Act | Chapter 2 Examination Fees | D3720 | β-hCG | 20000 | 2026-06-10 | |||||||
| drugs | 658604880 | Thrombin Plus (Thrombin) | 150,000 won | 2026-08-13 | ||||||||
| drugs | drugs | 672900421 | UK Taurokit 2% Injection (Taurolidine) (5g/250mL) | 100,000 | 2026-07-14 | |||||||
| drugs | drugs | 644705101 | Nebido Injection Vial (Testosterone Undecanoate) 4mL | 350,000 | 2026-06-23 | |||||||
| Act | Chapter 2 Examination Fees | D3002 | Microalbumin | 30,000 | 2026-03-20 | |||||||
| Act | Chapter 9 Treatment and Surgery Fees, etc. | Others | QZ9660902 | Robot-assisted surgery / Hysterectomy [Includes materials required for the procedure] | 13,000,000 | 17,000,000 | O | By surgery difficulty | 2026-10-02 | |||
| Act | Chapter 9 Treatment and Surgery Fees, etc. | Others | QZ9660901 | Robot-assisted surgery / Myomectomy [Includes materials required for the procedure] | 13,000,000 | 18,000,000 | O | By surgery difficulty | 2026-10-02 | |||
| Act | Chapter 9 Treatment and Surgery Fees, etc. | Others | QZ9660903 | Robot-assisted surgery / Excision of adnexal tumors [Includes materials required for the procedure] | 11,000,000 | 17,000,000 | O | By surgery difficulty | 2026-10-02 | |||
| Act | Chapter 9 Treatment and Surgery Fees, etc. | Others | QZ9660000 | Robot-assisted surgery / Others [Includes materials required for the procedure] | 14,000,000 | 16,000,000 | O | By surgery difficulty | 2026-10-02 | |||
| Act | Chapter 2 Examination Fees | C2290A | Total IgE non-covered | 20,000 | 2026-03-21 | |||||||
| drugs | drugs | Mint Condition Customized IV Care Program | 50,000 | 100,000 | Based on one use | 2026-03-09 | ||||||
| therapeutic material | therapeutic material | BM0600CA | CGM CareSense Air | 100,000 | 2026-03-05 | |||||||
| therapeutic material | therapeutic material | BM0600EC | CGM Libre | 150,000 | 2025-07-31 | |||||||
| drugs | drugs | 670801351 | Maunzaro Pre-filled Pen Injection 10 mg/0.5 mL (Terzepatide) [4 pens] | 580,000 | 2026-07-31 | |||||||
